Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Post-ERCP Acute Pancreatitis by Heme-oxygenase Activation Through the Administration of Hemin : a Prospective, Randomized Double Blind Controlled Trial

NCT01855841 is registered in ClinicalTrials.gov with Erasme University Hospital as lead sponsor.

NCT NCT01855841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01855841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Post-ERCP Acute Pancreatitis by Heme-oxygenase Activation Through the Administration of Hemin : a Prospective, Randomized Double Blind Controlled Trial
Lead sponsor
Erasme University Hospital
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2012
Completion date
June 30, 2021
Enrollment
284 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp acute pancreatitis